SCHEMBL32665401

SCHEMBL32665401

COc1cccc(-c2nnc3ccc(Cl)nn23)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.62
LRRK2 Q5S007 4/20 0.57
MAPT P10636 5/20 0.52
HIF1A Q16665 4/20 0.52
RAB9A P51151 3/20 0.52
DPP4 P27487 1/20 0.52
HPGD P15428 5/20 0.51
KDM4E B2RXH2 3/20 0.51
HSD17B10 Q99714 2/20 0.51
NPSR1 Q6W5P4 4/20 0.51
TSHR P16473 3/20 0.51
USP2 O75604 1/20 0.51
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
CDK2 P24941 1/20 0.49
CSNK1D P48730 1/20 0.49
MAPKAPK2 P49137 1/20 0.49
GSK3A P49840 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15365361 1.00 PIM1 (0.62) PIM1LRRK2MAPTHIF1ARAB9A
SCHEMBL29617977 0.84 DPP4 (0.54) LRRK2MAPTDPP4HPGDKDM4E
SCHEMBL24401671 0.84 DPP4 (0.54) LRRK2MAPTDPP4HPGDKDM4E
SCHEMBL15364726 0.83 ALDH1A1 (0.66) PIM1LRRK2MAPTRAB9ADPP4
SCHEMBL32665417 0.81 DYRK3 (0.58) PIM1LRRK2MAPTHIF1ADPP4
SCHEMBL12874554 0.79 DYRK3 (0.60) PIM1LRRK2MAPTDPP4HPGD
SCHEMBL15365501 0.79 KDM4E (0.65) PIM1LRRK2MAPTRAB9ADPP4
SCHEMBL5620191 0.78 GRK5 (0.46) PIM1LRRK2MAPTDPP4HPGD
SCHEMBL5618794 0.78 DPP4 (0.69) PIM1LRRK2MAPTDPP4HPGD
SCHEMBL4784567 0.78 BRD4 (0.65) PIM1LRRK2MAPTHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022124-A1 THERAPEUTIC COMPOUNDS AND METHODS UNIV MINNESOTA (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022124-A1 THERAPEUTIC COMPOUNDS AND METHODS NR5A1, CYP17A1, CNR1 PIM1 4155/4885LRRK2 4722/4885MAPT 4516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.